Even stronger foreign exchange headwinds inhibit revenue growth from steadily improving elective procedural trends 

Procedural volumes appear to be steadily improving overall as the COVID pandemic comes close to the end of its third year. Despite the return of procedures, foreign currency headwinds in Q322 strengthened, negatively impacting reported revenue growth for most companies in markets outside the US. Global companies with a strong international presence were most adversely affected.

Among the many topics covered in detail in our comprehensive Q322 Total Joints Market Recap* are:

• Complete Q322 Total Joints Market Overview and Highlights
• SmartTRAK's Expert Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• Improving Procedural Volumes Leaning into Strengthening Foreign Exchange Headwinds
• Hips: Muscle-Sparing Solutions and New Products Driving Growth
• Knees: Assistive Tech Driving Implant Pull-Through
• Q322 Regulatory Highlights

Do you love keeping up with the latest trends in the Spine and OrthoBiologics/Regen medicine markets? Are you a closet investigative reporter who loves researching and analyzing what’s going on in the market? Are you looking for a position that leverages your industry knowledge, expertise and connections in new ways? If you are a current or former marketing, market research or business development professional who has worked with one of the major orthopedic/spine companies and looking for a career change, we would love to talk with you.

We are looking to strengthen our SmartTRAK Spine and OrthoBiologics/Regen modules with the addition of a qualified person with industry specific experience. All SmartTRAK analysts are former marketing, business development or R&D professionals with one of the major orthopedic/spine suppliers and, in fact, most have come to us via recommendations from our subscribers, as well as those in the industry. We believe that having a person of this caliber with relevant experience and deep insight on the market is a tremendous value-add we can offer SmartTRAK subscribers.

We are looking for someone with Spine and OrthoBiologics/Regen industry experience who is interested in working full-time. Click the button below to learn more and apply.

The potential of US reimbursement changes to Skin Substitutes weighed heavily on companies at SAWC Fall, yet subsequently, CMS decided to delay finalizing its proposed changes.

The Symposium on Advanced Wound Care (SAWC) Fall 2022 gathered for another year in Las Vegas. The exhibit hall was filled with most wound care manufacturers and though booth hours were short, the clinical attendees made the best of their time searching out the latest in wound care technologies.

In this article, SmartTRAK discusses:

• Alternative Product Developments to the Skin Substitute Market 
• Potential Impact of Proposed Reimbursement Changes
• The Top Four Companies by Revenue 
• CMS' Proposed Terminology Change from “Skin Substitute”
• Packaging Skin Substitutes as “Incident to” Supplies

In the market for Trauma & Extremities, companies continue to innovate with new product introductions as well as a value-based care approach that promotes supporting clinical evidence for new and existing products showing their benefits to the patient and the hospital. Manufacturers are investing in solutions beyond implants to differentiate themselves and gain share in the Trauma & Extremities markets. SmartTRAK has observed a variety of strategies and solutions in the fast-paced hallux valgus segment as well as investment in deformity correction and periprosthetic solutions. The following is a sample of SmartTRAK's recent Trauma & Extremities news and developments from around the world, compiled, curated and posted in real-time by the expert analysts at SmartTRAK.

We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry. If you'd like to receive these expert insights daily, Contact Us to learn more. Our users think it's the perfect way to start their day.

New Products:

• CAPTIVATE Cannulated Screw System* - Globus*
  

  Globus announced the launch of the CAPTIVATE Headed Cannulated Screw System in diameters 2.5/3.0 mm, 3.5/4.0 mm, 4.5/5.5 mm. SmartTRAK reviewed the products at OTA with Globus as the Company fills out its Trauma & Extremities portfolio. LinkedIn

• Stryker*

  Stryker launched the Gamma4 System, the next-gen IM nail system from the IM Nail market leader (45.6% US share in 2021) according to SmartTRAK’s Financial Dashboard. The new system features a precision pin, redefined nail design and integrated instrument.

For the first time in recent years, robotics was not a main headline in the academic program at NASS 2022, but SmartTRAK notes that the exhibit floor was buzzing with exciting new developments in enabling technology.

Although there were limited program sessions focused solely on enabling technology at NASS 2022, the floor was abuzz with digital solutions, including recently launched and upcoming products. Based on conversations with NASS exhibitors, SmartTRAK identified key trends in the market for spine enabling technology including new spine robotic systems, augmented reality (AR) platforms and compact navigation solutions, as well as advances in surgical planning and unveiling of digital ecosystems. These innovations will help drive double-digit growth in the US market for Spine Enabling Technologies.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

• Beyond Robotics: Leveraging Data and Ecosystems
• Battle Bots: New Spine Robots on Display
• Augmented Reality Positioned to Target ASCs
• Small-Footprint Platforms and Disposable Spinal Navigation
• Problem-Solving Differentiated Technology

Our expert analysts focus in on the latest advancements, key trends and takeaways from the Orthopedic Trauma Association (OTA) meeting in Tampa, Florida held October 12–15, 2022. Major trauma manufacturers showcased innovation through new product introductions.

Highlighting the latest research, technology developments and innovations taking place in orthobiologics and regenerative medicine at ICRS 2022

This year the International Cartilage Regenerative & Joint Preservation Society (ICRS) hosted its 16th World Congress in Berlin, Germany, and SmartTRAK covered it. This was the Society’s first in-person meeting since October 2019, and without a doubt, a very exciting moment for ICRS, its members and all who attended the event. For four days, industry stakeholders from around the world converged in Berlin to learn and hear about the latest research, technology developments and innovations taking place in orthobiologics and regenerative medicine. In this article, SmartTRAK gives a recap of some of the main topics presented during the meeting.

Among the many fascinating topics covered in the complete article, which can be downloaded here, are:

• The Role of Extracellular Vesicles 
• Use of Minced Cartilage
• Autologous, Matrix-induced Chondrogenesis 
• Feasibility of Gene Therapy
• Other Therapies of Tomorrow